Finance

Beta
Lists
IMR:ASX
Imricor Medical Systems, Inc
A$1.74
0.00%
(0.00) 1D
Jun 4, 4:10:15 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for IMR...
Open
A$1.74
High
A$1.76
Low
A$1.68
Mkt. cap
615.07M
Avg. vol.
302.89K
Volume
329.04K
52-wk high
A$2.25
52-wk low
A$1.14
EPS
-A$0.11
Shares outstanding
353.49M
Open
A$1.74
High
A$1.76
Low
A$1.68
Mkt. cap
615.07M
Avg. vol.
302.89K
Volume
329.04K
52-wk high
A$2.25
52-wk low
A$1.14
EPS
-A$0.11
Shares outstanding
353.49M
News stories
From sources across the web
About Imricor Medical Systems, Inc
CEO-
Employees-
FoundedJan 1, 2006
HeadquartersBurnsville, Minnesota, United States
SectorMedical device
Websiteimricor.com
Last report
Jan 27, 2026
Fiscal period
Q4 2025
EPS / Est. (USD)
- / -
Revenue / Est. (USD)
47.72K / -
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
98.44K
98.44K
47.72K
47.72K
Cost of goods sold
405.85K
405.85K
757.07K
757.07K
Cost of revenue
405.85K
405.85K
757.07K
757.07K
Research and development expenses
2.88M
2.88M
2.70M
2.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.37M
2.37M
2.43M
2.43M
Operating expense
5.25M
5.25M
5.13M
5.13M
Total operating expenses
5.65M
5.65M
5.89M
5.89M
Operating income
-5.56M
-5.56M
-5.84M
-5.84M
Other non operating income
-1.83M
-1.83M
1.80M
1.80M
EBT including unusual items
-6.57M
-6.57M
-6.09M
-6.09M
EBT excluding unusual items
-6.57M
-6.57M
-3.52M
-3.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.57M
-6.57M
-6.09M
-6.09M
Net profit margin
-6,674.94%
-6,674.94%
-12,759.82%
-12,759.82%
Earnings per share
-
-
-
-
Interest and investment income
240.95K
240.95K
349.20K
349.20K
Interest expense
-2.08K
-2.08K
-
-
Net interest expenses
238.86K
238.86K
349.20K
349.20K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.38M
-5.38M
-5.62M
-5.62M
Gain or loss from assets sale
719.00
719.00
12.12K
12.12K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer